3D model is for representation purpose only.
.
.
GFLGTKPKGTKPKGTKPKGTKPKG | glycolic acid | N-(4-Acetylphenyl)-5-bromo-2-hydroxybenzamide |
Identification | |
---|---|
ConjuPepDB ID | cpd00127 |
Smiles | |
Inchi Key | InChIKey=ADGVTDPWISULLE-AVGWRIMJSA-N |
Molecular weight | 2824.48 |
Molecular formula | C128H206BrN35O32 |
Chemical name | Peptide information |
Sequence (one letter) | GFLGTKPKGTKPKGTKPKGTKPKG |
Length | 24 |
Peptide name | N/A |
External ID | |
---|---|
CAS number | 2100270-32-2 |
Other information | |
---|---|
Application | Antimicrobial therapy, anti-tuberculosis |
Additional function | Target cell-directed delivery and fluorescent labeling |
Pharmacological class | antimicrobial, antibacterial |
Conjugate type | amide |
Linker | N/A |
Linker Type | glycolic acid |
Small molecule | N-(4-Acetylphenyl)-5-bromo-2-hydroxybenzamide |
Small molecule CAS | 1007653-77-1 |
Small molecule structure | |
Structure method | 1H- and 13C-NMR |
Calculated properties | |
---|---|
LogP | -13.71804 |
Rotatable bonds | 90 |
H bond donor | 35 |
H bond acceptor | 41 |
Polar surface area (PSA) | 1066.33000 |
Citations | |||||
---|---|---|---|---|---|
ID | Title | Year | Authors | Journal | DOI |
In vitro biological evaluation of new antimycobacterial salicylanilide-tuftsin conjugates | 2017 | European Journal of Medicinal Chemistry | European Journal of Medicinal Chemistry |